The value of postoperative HLA-DR expression and high mobility group box 1 level in predictive diagnosis of sepsis in percutaneous nephrolithotomy surgery

Abstract Objective To analyze the value of postoperative human leukocyte antigen-DR (HLA-DR) expression and high mobility group box 1 (HMGB1) level in predictive diagnosis of postoperative sepsis for patients with percutaneous nephrolithotomy (PCNL) surgery. Methods The present prospective observational study included 387 patients with renal calculus who received PCNL surgery from January 2017 to October 2020 in our hospital. After exclusion criteria, 33 patients with sepsis and 78 patients with no sepsis remained. All patients received PCNL surgery. Sepsis definition is according to the third international consensus definitions for sepsis and septic shock (Sepsis-3). The data of the HMGB1, c-reactive protein (CRP), interleukin-6 (IL-6), procalcitonin (PCT) and HLA-DR expression were collected within admission and 24 h and 72 h after surgery. Postoperative HMGB1 levels and HLA-DR expression at 24 h and 72 h were respectively compared between the two groups using t test. ROC cure was used to analyze the value of postoperative HLA-DR expression and HMGB1 level in predictive diagnosis of sepsis. Results The positive rate of urine culture and the time of hospitalization time in patients with sepsis were significantly higher than those in patients with no sepsis. Sepsis group had higher levels of HMGB1 at post-24 h ((93.07 ± 11.37) ng/mL vs (75.41 ± 4.85) ng/mL), p < 0.05) and 72 h ((96.58 ± 12.12) ng/mL vs (81.16 ± 8.86) ng/mL), p < 0.05) than nosepsis group. Meanwhile, sepsis group had lower expression of HLA-DR at post-24 h ((50.01 ± 7.42) % vs (69.32 ± 10.58) %), p < 0.05) and 72 h ((54.85 ± 9.45) % vs (69.98 ± 11.00) %), p < 0.05) than non-sepsis group. ROC analysis showed that the HLA-DR expression at postoperative 24 h had highest predictive value in the diagnosis of sepsis, the AUC of HLA-DR was 0.934, cutoff value 56.19%, with sensitivity 89.7%, specificity 81.8%. Conclusion Postoperative HLA-DR and HMGB1 can both be used as a predictive diagnosis of sepsis for patients with renal calculus received PCNL surgery. Highlights Sepsis group had higher levels of high mobility group box 1 at post-24 h and 72 h than nosepsis group. Sepsis group had lower expression of HLA-DR at post-24 h and 72 h than nosepsis group. Postoperative HLA-DR and HMGB1 can both be used as a predictive diagnosis of sepsis for patients with renal calculus received PCNL surgery.

[1]  D. Shkarupa,et al.  A Feasibility of Percutaneous Nephrolithotomy in Positive Urine Culture: A Single Center Retrospective Study. , 2020, Urology journal.

[2]  Iekhsan Othman,et al.  Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling. , 2019, European journal of pharmacology.

[3]  T. Billiar,et al.  Location is the key to function: HMGB1 in sepsis and trauma‐induced inflammation , 2019, Journal of leukocyte biology.

[4]  M. Bauer,et al.  Late Peaks of HMGB1 and Sepsis Outcome: Evidence for Synergy With Chronic Inflammatory Disorders. , 2019, Shock.

[5]  B. Brumback,et al.  Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis , 2017, Shock.

[6]  E. Schwedhelm,et al.  Human leucocyte antigen (HLA-DR) gene expression is reduced in sepsis and correlates with impaired TNFα response: A diagnostic tool for immunosuppression? , 2017, PloS one.

[7]  Sumit Suresh Bansal,et al.  Predictive factors for fever and sepsis following percutaneous nephrolithotomy: A review of 580 patients , 2017, Urology annals.

[8]  Hu Peng,et al.  Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. , 2017, Frontiers in bioscience.

[9]  A. Kirkpatrick,et al.  High Mobility Group Box-1 Protein and Outcomes in Critically Ill Surgical Patients Requiring Open Abdominal Management , 2017, Mediators of inflammation.

[10]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[11]  M. Menon,et al.  Trends in percutaneous nephrolithotomy use and outcomes in the United States. , 2013, The Journal of urology.

[12]  B. Kim,et al.  Predictive Factors for Bleeding During Percutaneous Nephrolithotomy , 2013, Korean journal of urology.

[13]  J. Timsit,et al.  Inter‐laboratory assessment of flow cytometric monocyte HLA‐DR expression in clinical samples , 2013, Cytometry. Part B, Clinical cytometry.

[14]  Michael Bauer,et al.  New Approaches to Sepsis: Molecular Diagnostics and Biomarkers , 2012, Clinical Microbiology Reviews.

[15]  R. Hotchkiss,et al.  Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.

[16]  B. Allaouchiche,et al.  Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma , 2010, Critical care.

[17]  N. Unterwalder,et al.  High-Mobility Group Box-1 Protein Serum Levels Do Not Reflect Monocytic Function in Patients with Sepsis-Induced Immunosuppression , 2010, Mediators of inflammation.

[18]  F. Genel,et al.  Monocyte HLA-DR expression as predictor of poor outcome in neonates with late onset neonatal sepsis. , 2010, The Journal of infection.

[19]  R. Pirracchio,et al.  Monocytic HLA‐DR expression in intensive care patients: Interest for prognosis and secondary infection prediction * , 2009, Critical care medicine.

[20]  A. Ayala,et al.  Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock , 2007, Critical care medicine.

[21]  Yasuhiro Yamamoto,et al.  Relationship Between Effect of Polymyxin B–Immobilized Fiber and High-Mobility Group Box-1 Protein in Septic Shock Patients , 2007, ASAIO journal.

[22]  Maurice Stephan Michel,et al.  Complications in percutaneous nephrolithotomy. , 2007, European urology.

[23]  B. Drénou,et al.  Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. , 2004, American journal of respiratory and critical care medicine.

[24]  K. Tracey,et al.  Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[25]  K. Tracey,et al.  HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.

[26]  M. Regan,et al.  A systematic study of host defense processes in badly injured patients. , 1986, Annals of surgery.